Health
Cathay Insurance Vietnam and SAWAD Launch One-Stop "Dual Finance" Programme
HO CHI MINH CITY, Vietnam, Dec. 29, 2023 /PRNewswire/ -- Cathay Insurance Vietnam has partnered with SAWAD to launch a one-stop "Dual Finance" programme which allows customers to apply for the financial support, and at the same time, purchase separate mandatory insurance coverage in a streamlined...
2023-12-29 17:48
7099
ANAESTHESIOLOGIST HERO, DOCTOR'S QUICK THINKING SAVES CYCLIST'S LIFE DURING LEKAS NIGHT RIDE 2023
Off-duty doctor's decisive action and collaboration with fellow physician-cyclists lead to a successful resuscitation and life-saving measures. SELANGOR, MALAYSIA, Dec. 29, 2023 /PRNewswire/ -- In an extraordinary display of quick thinking and medical expertise, Dr. Shahridan Bin Mohd Fathil, an ...
2023-12-29 17:20
3233
Positive Results In The Interim Analysis Of The Clinical Trial Of Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
TAIZHOU, China, Dec. 29, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the novel adjuvanted recombinant shingles vaccine REC610 independently developed by the Company has recently achieved positive...
2023-12-29 12:33
2582
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses through at least 3-weeks-- --Durable efficacy and PK profile expected to support convenient dosing interval of ≥2-weeks, compared to daily or weekly d...
2023-12-29 07:30
2440
Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
YANGZHOU, China, Dec. 28, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today that it has ent...
2023-12-28 22:00
5685
HANSIZHUANG Sets Sail in Indonesia Market
* The 1st China anti-PD-1 monoclonal antibody successfully approved in Southeast Asia - * The 1st overseas approval of HANSIZHUANG, highlighting another major milestone of Henlius' global strategy after HANQUYOU - * Along with KGbio and other partners to develop and launch HANSIZHUANG in ov...
2023-12-28 21:51
3436
Heranova Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women's Health
BOSTON and HONG KONG, Dec. 28, 2023 /PRNewswire/ -- Heranova Lifesciences Holding Ltd. ("Heranova") today announced the successful completion of aUSD 13.5 million seed and seed+ financing to develop and offer integrated Women's Health solutions worldwide. This funding will be used to launch a ...
2023-12-28 21:00
1730
RemeGen's Pioneering RC88 Receives IND Approval from US FDA for Platinum-Resistant Recurrent Ovarian Cancer Treatment
YANTAI, China, Dec. 28, 2023 /PRNewswire/ -- RemeGen Co. Ltd.
2023-12-28 15:45
2244
Visionary Excellence Recognized: VISTA Eye Specialist Clinches Top Honor at Health and Wellness Brand Awards
PETALING JAYA, Malaysia, Dec. 28, 2023 /PRNewswire/ -- VISTA Eye Specialist ('VISTA'),Malaysia's premier eye care group, proudly announces its recent accolade: the coveted Malaysia Health and Wellness Brand Awards ('Award') in the Health Institutions Category for the 4th time. The Award, organize...
2023-12-28 08:00
2108
Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China
ROCKVILLE, Md. and SUZHOU, China, Dec. 28, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
2023-12-28 08:00
3750
Jung Kwan Jang Launches a Limited-edition Red Ginseng, Marking its 124th Anniversary
SEOUL, South Korea, Dec. 28, 2023 /PRNewswire/ -- On December 1, 2023,
Jung Kwan Jang honors its 124th anniversary with the unveiling of the Red
Ginseng Heritage Edition, a tribute to the company's respect for Korean
cultural heritage.
2023-12-28 07:00
2970
Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA
YANTAI, China, Dec. 27, 2023 /PRNewswire/ -- Boan Biotech today announced that two of its Claudin18.2-targeted investigational drugs have been granted the Orphan Drug Designation (ODD) for the treatment of pancreatic cancer by the U.S. Food and Drug Administration (FDA): one is BA1105, an innovat...
2023-12-27 20:50
3144
Seegene obtains ISO45001 certification
SEOUL, South Korea, Dec. 27, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced that it has achieved an ISO45001 certification on December 27. The Occupational Health and Safety Management System (ISO ...
2023-12-27 20:00
2394
AIA Hong Kong "Health & Wellness Survey" Defies Stereotypes: Family Overtakes Money as Key to Happiness, Redefines Health and Happiness
HONG KONG, Dec. 27, 2023 /PRNewswire/ -- Are Hong Kong people happy? AIA Hong Kong, a leading advocate for mental and physical health, unveiled the findings of its inaugural "Health & Wellness Survey#". It interviewed 400 Hong Kong residents and delivered a finding that challenges conventional be...
2023-12-27 16:03
2254
Rx-360® Announces 2024 Board of Directors
PHILADELPHIA, Dec. 27, 2023 /PRNewswire/ -- Rx-360® is pleased to announce its 2024 Board of Directors. As a non-profit, the Board of Directors is positioned to continue driving the Rx-360® mission of pharmaceutical supply chain security, material quality, and patient safety. This announcement fo...
2023-12-27 13:00
2613
Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024
CBL-514 Phase 2 Study Results for local fat reduction demonstrated 85.7% and 76.2% of participants lost at least 150mL and 200mL of abdominal subcutaneous fat in the treated area after receiving CBL-514 treatment(s). NEW TAIPEI CITY, Dec. 26, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Cal...
2023-12-27 11:49
1770
PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site
NANJING, China, Dec. 26, 2023 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (Stock code: 300725.SZSE), a global, fully integrated CRDMO company, focusing on innovative chemistry and low-carbon manufacturing, has announced opening of a new high potency API (HPAPI) GMP facility (OEB-5 and ab...
2023-12-27 11:37
2052
Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension
ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
2023-12-27 08:00
3640
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs
SHANGHAI, Dec. 26, 2023 /PRNewswire/ -- Jemincare, a leading pharmaceutical company fromChina, announced that its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., recently received 6 approvals of clinical trials for its innovative drugs in the field of cancer, kidney ...
2023-12-26 17:26
1960
Panlin Capital Announces Second Closing for its Healthcare Venture Capital Fund; Has Raised a Total of RMB 1.5 Billion in the Last Two Years
SHANGHAI, Dec. 26, 2023 /PRNewswire/ -- Recently, Panlin Capital announced that Hangzhou Panlin Xukang Fund, a venture capital fund focusing on innovative biopharmaceuticals, innovative medical device and biotechnology, has completed its second closing. This is the first fund that Panlin Capital ...
2023-12-26 12:59
2871
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Transformation of Asia's Process Industries To Get A Boost Through Region's First Dedicated Process Technology Show
[Picked up by 279 media titles]
2024-11-12 16:00
Most Read
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5754
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5654
